Lung Cancers Completed Phase 2 Trials for Defactinib (DB12282)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01951690Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung CancerTreatment